Table 2 Descriptive statistics for key study variables
Measurea | Analytic sample (N = 55) | Participants excluded in fMRI QC (N = 55) | Significant difference between the analytic and excluded samples |
|---|---|---|---|
Internalizing symptoms (raw scores) | 5.44 (4.65); 0–19 | 6.09 (6.24); 0–29 | No |
Clinical symptom levels (T-score > 63) | 6 (11%) | 7 (13%) | |
Borderline symptom levels (T-score: 60–63) | 3 (5%) | 5 (9%) | |
Not clinically significant symptom levels (T-score <60) | 46 (84%) | 43 (78%) | |
Anxiety symptoms (raw scores) | 2.25 (1.85); 0–7 | 2.47 (2.32); 0–9 | No |
Depressive symptoms (raw scores) | 1.42 (1.58); 0–9 | 1.71 (2.57); 0–14 | No |
Externalizing symptoms (raw scores) | 5.69 (5.28); 0–24 | 6.35 (6.08); 0–30 | No |
Clinical symptom levels (T-score >63) | 3 (5%) | 4 (7%) | |
Borderline symptom levels (T-score: 60–63) | 3 (5%) | 6 (11%) | |
Not clinically significant symptom levels (T-score <60) | 49 (90%) | 45 (82%) | |
Alpha diversity | |||
Shannon Index | 3.26 (0.77); 1.57–5.14 | 3.25 (0.67); 0.80–4.48 | No |
Observed Features | 81.44 (24.50); 48–173 | 76.04 (19.43); 38–141 | No |
Pielou Evenness | 0.51 (0.10); 0.28–0.69 | 0.52 (0.09); 0.14–0.64 | No |
Faith’s phylogenetic diversity | 5.73 (1.76); 3.24–12.65 | 5.45 (1.82); 2.94–13.39 | No |
